Sight Sciences, Inc. (SGHT) has a MoatMap StockRank of 15/100 based on Quality (39/100), Value (40/100), and Momentum (21/100) factor scores. The current signal is STRONG SELL. Sight Sciences is a small-cap medical device company with weak pricing power and high sales-and-marketing expenses relative to its revenue.
Sight Sciences, Inc. is a medical device company dedicated to developing and commercializing innovative surgical and non-surgical solutions for prevalent eye diseases, primarily glaucoma and dry eye. The company leverages proprietary technologies like its OMNI Surgical System and TearCare System to address significant unmet needs, establishing a niche in the ophthalmology market.
| Price | $4.85 |
| Market Cap | $275M |
| P/E (Forward) | -6.97 |
| Price/Book | 3.85 |
| Return on Equity | -56.6% |
| Return on Invested Capital | -31.9% |
| Debt/Equity | 77.47 |
| Gross Margin | 86.2% |
| Operating Margin | -35.6% |
| Revenue Growth | 12.5% |
| Free Cash Flow | $-9M |
Sight Sciences, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).